Research criteria for subcortical vascular dementia in clinical trials.
By Timo Erkinjuntti. Journal of neural transmission. Supplementum, 2000
653 citations recorded by the source corpus.
Subfields: Neurology
View Paper: https://www.semanticscholar.org/paper/e6497da99378cc29176bdf43bf3e802699c9b54c
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Neurology
- Kaj Blennow
- Henrik Zetterberg
- Oskar Hansson
- Philip Scheltens
- Perminder S. Sachdev
- Helena Chui
- N. Prins
- K. Jellinger
Citations in the corpus
- Retinal vascular image analysis as a potential screening tool for cerebrovascular disease: a rationale based on homology between cerebral and retinal microvasculatures (2005, background): “It is now recognized that cerebrovascular smallvessel disease with white-matter lesions and lacunar infarcts is an important cause of cognitive impairment of cerebrovascular origin (Erkinjuntti et al. 2000; Inzitari et al. 2000; Jellinger, 2002; Mok et al. 2004).”
- Diagnostic criteria for vascular cognitive disorders: a VASCOG statement (2014, background): “(9) Hereditary angiopathies—cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy, CADASIL; cerebral autosomal recessive arteriopathy with subcortical autosomal recessive leukoencephalopathy, CARASIL, etc.”
- CSF biomarkers and incipient Alzheimer disease in patients with mild cognitive impairment. (2009, methodology): “A 142 levels were determined using a sandwich ELISA (Innotest -amyloid[1-42]), specifically constructed to measure A containing both the 1st and 42nd amino acids, as previously described.”